\chapter{Supplementary figures}

% western blot heatmap
\begin{figure}[ht]
\centering
\includegraphics[width=0.5\textwidth]{figures/appendix/western_gcn2_supplementary.pdf}
\caption[GCN2 and eIF2$\alpha$ western blot ]{Western blot demonstrating dose-dependent NCP26 canonical ISR activation with GCN2 and eIF2$\alpha$ phosphorylation. AMO-1 and MM.1S myeloma cell lines used.
}
\label{fig:sup_western}
\end{figure}
%%

% Marker table
\input{text/Chapter_6_single-cell_PRS/markers_table.tex}

% inferCNV
\begin{figure}[htb]
    \centering
    \includegraphics[width=\textwidth]{figures/Results/single_cell/data_processing/inferCNV_relapse.pdf}
    \caption[inferCNV- newly-diagnosed MM]{InferCNV results for the newly-diagnosed MM dataset.
    [a and b] InferCNV heatmaps.
        The top panel shows expression values for the reference `normal' cells.
        The bottom panel shows expression values for the suspected malignant cells (clusters 2, 7 and 13), and other B-cell lineages (B cells and plasma cells).
        Red indicates chromosomal region amplifications and blue indicates chromosomal region deletions.
    a) De-noised inferCNV results.
    b) Hidden Markov-Model (HMM) copy number variation (CNV) region predictions.
        Only some chromosomal region gains predicted in MM clusters 2 and 13, and the plasma cell cluster.
    }
    \label{fig:inferCNV_naive}
\end{figure}
%